Who
Stefan Loren
Other role
Company insider
Files Form 4 as: Director and Other, Cellectar Biosciences; Director, Genvec; Director, Marina Biotech; Director, Polymedix.
In numbers
- Trades disclosed
- 44
- Buys
- 2
- Sells
- 0
- Bought
- $9,870
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 31 Jul 2008
- Last trade
- 8 Jul 2026
- Last filed
- 10 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jul 2026filed 10 Jul 2026 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 8 Jul 2026filed 8 Jul 2026 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 8 Jul 2026filed 8 Jul 2026 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 14 Feb 2025filed 18 Feb 2025 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 28 Jun 2023filed 28 Jun 2023 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 24 Jun 2022filed 1 Aug 2022 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 30 Jun 2021filed 2 Jul 2021 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,000 at $0.00 | filing |
| 24 Jun 2020filed 25 Jun 2020 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 13 Jun 2019filed 14 Jun 2019 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 12 Oct 2018filed 15 Oct 2018 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 16 Jun 2017filed 20 Jun 2017 | Genvec | SEC FORM 4 Code M | $5,7001,500 at $3.80 | filing |
| 16 Jun 2017filed 20 Jun 2017 | Genvec | SEC FORM 4 Code D | —1,207 | filing |
| 16 Jun 2017filed 20 Jun 2017 | Genvecoption or derivative | SEC FORM 4 Code M | $5,7001,500 at $3.80 | filing |
| 31 May 2017filed 1 Jun 2017 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 3 Jan 2017filed 4 Jan 2017 | Marina Biotechoption or derivative | SEC FORM 4 Code A | —81,000 at $0.00 | filing |
| 15 Nov 2016filed 17 Nov 2016 | Marina Biotechoption or derivative | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 20 Oct 2016filed 24 Oct 2016 | Genvecoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 5 Jul 2016filed 7 Jul 2016 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | $22522,500 at $0.01 | filing |
News
No headline names them, or the companies they trade most, lately.